|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07C 229/12 | (2006.01) |
| C07D 233/72 | (2006.01) | ||
| A61K 9/127 | (2006.01) | ||
| C07C 271/20 | (2006.01) | ||
| C07C 279/12 | (2006.01) | ||
| C07C 279/28 | (2006.01) | ||
| C07C 279/32 | (2006.01) | ||
| C07C 311/07 | (2006.01) | ||
| C07C 311/49 | (2006.01) | ||
| C07C 321/14 | (2006.01) | ||
| C07D 249/04 | (2006.01) | ||
| C07D 263/20 | (2006.01) | ||
| C07C 237/04 | (2006.01) | ||
| C07C 237/06 | (2006.01) | ||
| C07D 265/33 | (2006.01) | ||
| C07D 271/06 | (2006.01) | ||
| C07D 271/10 | (2006.01) | ||
| C07D 207/27 | (2006.01) | ||
| C07D 277/38 | (2006.01) |
| (11) | Patento numeris | 3350157 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16781895.4 |
| Europos patento paraiškos padavimo data | 2016-09-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-01-05 |
| (46) | Apibrėžties vertimo paskelbimo data | 2022-02-25 |
| (86) | Numeris | PCT/US2016/052352 |
| Data | 2016-09-16 |
| (87) | Numeris | WO 2017/049245 |
| Data | 2017-03-23 |
| (30) | Numeris | Data | Šalis |
| 201562220085 P | 2015-09-17 | US | |
| 201562220091 P | 2015-09-17 | US | |
| 201562252316 P | 2015-11-06 | US | |
| 201562253433 P | 2015-11-10 | US | |
| 201562266460 P | 2015-12-11 | US | |
| 201662333557 P | 2016-05-09 | US | |
| 201662382740 P | 2016-09-01 | US | |
| 201662393940 P | 2016-09-13 | US |
| (72) |
BENENATO, Kerry, E. , US
KUMARASINGHE, Ellalahewage, Sathyajith , US
CORNEBISE, Mark , US
|
| (73) |
ModernaTX, Inc. ,
200 Technology Square, Cambridge, MA 02139,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu |
| COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-09-05 | 10 | 231.00 EUR |
| 2026-09-16 |